Protalix BioTherapeutics (PLX) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -33.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.02% |
| Dec 31, 2025 | -43.62% |
| Sep 30, 2025 | -32.34% |
| Jun 30, 2025 | 164.99% |
| Mar 31, 2025 | -28.60% |
| Dec 31, 2024 | -267.04% |
| Sep 30, 2024 | 469.85% |
| Jun 30, 2024 | -333.82% |
| Mar 31, 2024 | 141.13% |
| Dec 31, 2023 | 682.26% |
| Sep 30, 2023 | -260.48% |
| Jun 30, 2023 | 237.84% |
| Mar 31, 2023 | 8.30% |
| Dec 31, 2022 | -113.84% |
| Sep 30, 2022 | -63.95% |
| Jun 30, 2022 | -152.67% |
| Mar 31, 2022 | -40.67% |
| Dec 31, 2021 | 811.11% |
| Sep 30, 2021 | 237.25% |
| Jun 30, 2021 | 32.55% |
| Mar 31, 2021 | 484.85% |
| Dec 31, 2020 | 87.43% |
| Sep 30, 2020 | -73.98% |
| Jun 30, 2020 | 472.97% |
| Mar 31, 2020 | -61.18% |
| Dec 31, 2019 | -83.52% |
| Sep 30, 2019 | 276.92% |
| Jun 30, 2019 | -74.48% |
| Mar 31, 2019 | -31.73% |
| Dec 31, 2018 | -194.14% |
| Sep 30, 2018 | -24.64% |
| Jun 30, 2018 | -55.11% |
| Mar 31, 2018 | 13.18% |
| Dec 31, 2017 | 147.86% |
| Sep 30, 2017 | -12.10% |
| Jun 30, 2017 | -0.31% |
| Mar 31, 2017 | -12.35% |
| Dec 31, 2016 | 2,825.00% |
| Sep 30, 2016 | 22.66% |
| Jun 30, 2016 | 39.06% |
| Mar 31, 2016 | 153.54% |
| Mar 31, 2015 | -62.36% |
| Mar 31, 2014 | -59.03% |
| Dec 31, 2013 | -11.55% |
| Sep 30, 2013 | -57.53% |
| Jun 30, 2013 | 194.94% |
| Mar 31, 2013 | -20.74% |
| Dec 31, 2012 | -64.35% |
| Sep 30, 2012 | -21.83% |
| Jun 30, 2012 | -83.22% |
| Mar 31, 2012 | -68.89% |
| Dec 31, 2011 | -32.24% |
| Sep 30, 2011 | -26.66% |